132 related articles for article (PubMed ID: 20521072)
1. S100A2 in cancerogenesis: a friend or a foe?
Wolf S; Haase-Kohn C; Pietzsch J
Amino Acids; 2011 Oct; 41(4):849-61. PubMed ID: 20521072
[TBL] [Abstract][Full Text] [Related]
2. [Thermodynamics of zinc binding to human S100A2].
Tsvetkov FO; Devred F; Makarov AA
Mol Biol (Mosk); 2010; 44(5):938-42. PubMed ID: 21090249
[TBL] [Abstract][Full Text] [Related]
3. Implications on zinc binding to S100A2.
Koch M; Bhattacharya S; Kehl T; Gimona M; Vasák M; Chazin W; Heizmann CW; Kroneck PM; Fritz G
Biochim Biophys Acta; 2007 Mar; 1773(3):457-70. PubMed ID: 17239974
[TBL] [Abstract][Full Text] [Related]
4. Purification and crystallization of the human EF-hand tumour suppressor protein S100A2.
Koch M; Diez J; Fritz G
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Nov; 62(Pt 11):1120-3. PubMed ID: 17077493
[TBL] [Abstract][Full Text] [Related]
5. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
[TBL] [Abstract][Full Text] [Related]
6. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
7. Metal ions modulate the folding and stability of the tumor suppressor protein S100A2.
Botelho HM; Koch M; Fritz G; Gomes CM
FEBS J; 2009 Mar; 276(6):1776-86. PubMed ID: 19267779
[TBL] [Abstract][Full Text] [Related]
8. Transgenic expression of S100A2 in hairless mouse skin enhances Cxcl13 mRNA in response to solar-simulated radiation.
Li Y; Gudjonsson JE; Woods TL; Zhang T; Johnston A; Stoll SW; Elder JT
Arch Dermatol Res; 2009 Mar; 301(3):205-17. PubMed ID: 18773213
[TBL] [Abstract][Full Text] [Related]
9. Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells.
Haase-Kohn C; Wolf S; Lenk J; Pietzsch J
Biochem Biophys Res Commun; 2011 Sep; 413(3):494-8. PubMed ID: 21924240
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
11. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion.
Wasuworawong K; Roytrakul S; Paemanee A; Jindapornprasert K; Komyod W
Dis Markers; 2015; 2015():629367. PubMed ID: 25999659
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of S100A2 in lymph node metastases of head and neck cancer.
Zhang X; Hunt JL; Shin DM; Chen ZG
Head Neck; 2007 Mar; 29(3):236-43. PubMed ID: 17123307
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of Ca2+ -free S100A2 at 1.6-A resolution.
Koch M; Diez J; Fritz G
J Mol Biol; 2008 May; 378(4):933-42. PubMed ID: 18394645
[TBL] [Abstract][Full Text] [Related]
14. Mapping the zinc ligands of S100A2 by site-directed mutagenesis.
Stradal TB; Troxler H; Heizmann CW; Gimona M
J Biol Chem; 2000 May; 275(18):13219-27. PubMed ID: 10788426
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into human Zn(2+)-bound S100A2 from NMR and homology modeling.
Randazzo A; Acklin C; Schäfer BW; Heizmann CW; Chazin WJ
Biochem Biophys Res Commun; 2001 Oct; 288(2):462-7. PubMed ID: 11606065
[TBL] [Abstract][Full Text] [Related]
16. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
Buckley NE; D'Costa Z; Kaminska M; Mullan PB
Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma.
Tsai WC; Tsai ST; Jin YT; Wu LW
Mol Cancer Res; 2006 Aug; 4(8):539-47. PubMed ID: 16908593
[TBL] [Abstract][Full Text] [Related]
18. Identification of S100A2 as a target of the DeltaNp63 oncogenic pathway.
Hibi K; Fujitake S; Takase T; Kodera Y; Ito K; Akiyama S; Shirane M; Nakao A
Clin Cancer Res; 2003 Sep; 9(11):4282-5. PubMed ID: 14519656
[TBL] [Abstract][Full Text] [Related]
19. S100A2, a putative tumor suppressor gene, regulates in vitro squamous cell carcinoma migration.
Nagy N; Brenner C; Markadieu N; Chaboteaux C; Camby I; Schäfer BW; Pochet R; Heizmann CW; Salmon I; Kiss R; Decaestecker C
Lab Invest; 2001 Apr; 81(4):599-612. PubMed ID: 11304580
[TBL] [Abstract][Full Text] [Related]
20. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity.
Mueller A; Schäfer BW; Ferrari S; Weibel M; Makek M; Höchli M; Heizmann CW
J Biol Chem; 2005 Aug; 280(32):29186-93. PubMed ID: 15941720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
